Determination of a key antigen for immunological intervention to target the latent stage of toxoplasma gondii

Qila Sa, Eri Ochiai, Ashish Tiwari, Jeremi Mullins, Nilabh Shastri, Corinne Mercier, Marie France Cesbron-Delauw, Yasuhiro Suzuki

Research output: Contribution to journalArticle

Abstract

Toxoplasma gondii, an obligate intracellular protozoan parasite, establishes a chronic infection by forming cysts preferentially in the brain. Up to one third of the human population worldwide is estimated to be chronically infected with this parasite. However, there is currently no drug effective against the cyst form of the parasite. In addition, the protective immunity against the cysts remains largely unknown. We analyzed the molecular mechanisms by which the immune system detects host cells harboring the cysts to eliminate the latent stage of the parasite using mice with the H-2d haplotype, which are genetically resistant to the infection. Our study revealed that CD8+ immune T cells bearing TCR Vb8.1, 8.2 chain have a potent activity to remove T. gondii cysts from the brain. Our studies also uncovered that H-2Ld is the major Ag-presenting molecule to CD8+ T cells for initiating cyst elimination, and that CD8+Vb8.1, 8.2+ immune T cells recognize the N-terminal region (aa 41-152) of dense granule protein 6 (GRA6Nt) of the parasite presented by the H-2Ld molecule. Furthermore, CD8+ immune T cells induced by immunization with recombinant GRA6Nt were eventually capable of removing the cysts from the brain when transferred to infected immunodeficient mice lacking T cells. Thus, GRA6Nt is a novel and potent Ag to activate CD8+ T cells capable of removing T. gondii cysts. These observations offer a basis for immunological intervention to combat chronic infection with T. gondii by targeting the persistent cysts of the parasite.

Original languageEnglish (US)
Pages (from-to)4425-4434
Number of pages10
JournalJournal of Immunology
Volume198
Issue number11
DOIs
StatePublished - Jun 1 2017
Externally publishedYes

Fingerprint

Toxoplasma
Cysts
Antigens
Parasites
T-Lymphocytes
Brain
Toxoplasmosis
Infection
Haplotypes
Immune System
Immunity
Immunization

ASJC Scopus subject areas

  • Immunology

Cite this

Determination of a key antigen for immunological intervention to target the latent stage of toxoplasma gondii. / Sa, Qila; Ochiai, Eri; Tiwari, Ashish; Mullins, Jeremi; Shastri, Nilabh; Mercier, Corinne; Cesbron-Delauw, Marie France; Suzuki, Yasuhiro.

In: Journal of Immunology, Vol. 198, No. 11, 01.06.2017, p. 4425-4434.

Research output: Contribution to journalArticle

Sa, Q, Ochiai, E, Tiwari, A, Mullins, J, Shastri, N, Mercier, C, Cesbron-Delauw, MF & Suzuki, Y 2017, 'Determination of a key antigen for immunological intervention to target the latent stage of toxoplasma gondii', Journal of Immunology, vol. 198, no. 11, pp. 4425-4434. https://doi.org/10.4049/jimmunol.1700062
Sa, Qila ; Ochiai, Eri ; Tiwari, Ashish ; Mullins, Jeremi ; Shastri, Nilabh ; Mercier, Corinne ; Cesbron-Delauw, Marie France ; Suzuki, Yasuhiro. / Determination of a key antigen for immunological intervention to target the latent stage of toxoplasma gondii. In: Journal of Immunology. 2017 ; Vol. 198, No. 11. pp. 4425-4434.
@article{bb887187552046b6a15794e7c50b3463,
title = "Determination of a key antigen for immunological intervention to target the latent stage of toxoplasma gondii",
abstract = "Toxoplasma gondii, an obligate intracellular protozoan parasite, establishes a chronic infection by forming cysts preferentially in the brain. Up to one third of the human population worldwide is estimated to be chronically infected with this parasite. However, there is currently no drug effective against the cyst form of the parasite. In addition, the protective immunity against the cysts remains largely unknown. We analyzed the molecular mechanisms by which the immune system detects host cells harboring the cysts to eliminate the latent stage of the parasite using mice with the H-2d haplotype, which are genetically resistant to the infection. Our study revealed that CD8+ immune T cells bearing TCR Vb8.1, 8.2 chain have a potent activity to remove T. gondii cysts from the brain. Our studies also uncovered that H-2Ld is the major Ag-presenting molecule to CD8+ T cells for initiating cyst elimination, and that CD8+Vb8.1, 8.2+ immune T cells recognize the N-terminal region (aa 41-152) of dense granule protein 6 (GRA6Nt) of the parasite presented by the H-2Ld molecule. Furthermore, CD8+ immune T cells induced by immunization with recombinant GRA6Nt were eventually capable of removing the cysts from the brain when transferred to infected immunodeficient mice lacking T cells. Thus, GRA6Nt is a novel and potent Ag to activate CD8+ T cells capable of removing T. gondii cysts. These observations offer a basis for immunological intervention to combat chronic infection with T. gondii by targeting the persistent cysts of the parasite.",
author = "Qila Sa and Eri Ochiai and Ashish Tiwari and Jeremi Mullins and Nilabh Shastri and Corinne Mercier and Cesbron-Delauw, {Marie France} and Yasuhiro Suzuki",
year = "2017",
month = "6",
day = "1",
doi = "10.4049/jimmunol.1700062",
language = "English (US)",
volume = "198",
pages = "4425--4434",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "11",

}

TY - JOUR

T1 - Determination of a key antigen for immunological intervention to target the latent stage of toxoplasma gondii

AU - Sa, Qila

AU - Ochiai, Eri

AU - Tiwari, Ashish

AU - Mullins, Jeremi

AU - Shastri, Nilabh

AU - Mercier, Corinne

AU - Cesbron-Delauw, Marie France

AU - Suzuki, Yasuhiro

PY - 2017/6/1

Y1 - 2017/6/1

N2 - Toxoplasma gondii, an obligate intracellular protozoan parasite, establishes a chronic infection by forming cysts preferentially in the brain. Up to one third of the human population worldwide is estimated to be chronically infected with this parasite. However, there is currently no drug effective against the cyst form of the parasite. In addition, the protective immunity against the cysts remains largely unknown. We analyzed the molecular mechanisms by which the immune system detects host cells harboring the cysts to eliminate the latent stage of the parasite using mice with the H-2d haplotype, which are genetically resistant to the infection. Our study revealed that CD8+ immune T cells bearing TCR Vb8.1, 8.2 chain have a potent activity to remove T. gondii cysts from the brain. Our studies also uncovered that H-2Ld is the major Ag-presenting molecule to CD8+ T cells for initiating cyst elimination, and that CD8+Vb8.1, 8.2+ immune T cells recognize the N-terminal region (aa 41-152) of dense granule protein 6 (GRA6Nt) of the parasite presented by the H-2Ld molecule. Furthermore, CD8+ immune T cells induced by immunization with recombinant GRA6Nt were eventually capable of removing the cysts from the brain when transferred to infected immunodeficient mice lacking T cells. Thus, GRA6Nt is a novel and potent Ag to activate CD8+ T cells capable of removing T. gondii cysts. These observations offer a basis for immunological intervention to combat chronic infection with T. gondii by targeting the persistent cysts of the parasite.

AB - Toxoplasma gondii, an obligate intracellular protozoan parasite, establishes a chronic infection by forming cysts preferentially in the brain. Up to one third of the human population worldwide is estimated to be chronically infected with this parasite. However, there is currently no drug effective against the cyst form of the parasite. In addition, the protective immunity against the cysts remains largely unknown. We analyzed the molecular mechanisms by which the immune system detects host cells harboring the cysts to eliminate the latent stage of the parasite using mice with the H-2d haplotype, which are genetically resistant to the infection. Our study revealed that CD8+ immune T cells bearing TCR Vb8.1, 8.2 chain have a potent activity to remove T. gondii cysts from the brain. Our studies also uncovered that H-2Ld is the major Ag-presenting molecule to CD8+ T cells for initiating cyst elimination, and that CD8+Vb8.1, 8.2+ immune T cells recognize the N-terminal region (aa 41-152) of dense granule protein 6 (GRA6Nt) of the parasite presented by the H-2Ld molecule. Furthermore, CD8+ immune T cells induced by immunization with recombinant GRA6Nt were eventually capable of removing the cysts from the brain when transferred to infected immunodeficient mice lacking T cells. Thus, GRA6Nt is a novel and potent Ag to activate CD8+ T cells capable of removing T. gondii cysts. These observations offer a basis for immunological intervention to combat chronic infection with T. gondii by targeting the persistent cysts of the parasite.

UR - http://www.scopus.com/inward/record.url?scp=85019948042&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85019948042&partnerID=8YFLogxK

U2 - 10.4049/jimmunol.1700062

DO - 10.4049/jimmunol.1700062

M3 - Article

C2 - 28446567

AN - SCOPUS:85019948042

VL - 198

SP - 4425

EP - 4434

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 11

ER -